Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion type Assertion NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_head.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion description "[As the inflammatory responses in ALN patients are more severe than those in APN patients (higher CRP levels, longer duration of fever after antibiotic treatment), these findings suggest that the genetic variant in TLR-2 (rs3804100, T1350C) may protect the host from severe urinary tract infections as ALN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_provenance.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion evidence source_evidence_literature NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_provenance.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion SIO_000772 23484049 NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_provenance.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion wasDerivedFrom befree-2016 NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_provenance.
- NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_assertion wasGeneratedBy ECO_0000203 NP1059864.RANFQNZ4fv0Oesp5shqmJKJlGlAM-XD2HUvTkDFBhAPFs130_provenance.